QIV-HD clinical development and phase 3 safety and immunogenicity study results

Chang, Lee-Jah

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

QIV-HD clinical development and phase 3 safety and immunogenicity study results

October 23. 2019
By Chang, Lee-Jah
Series: ACIP meeting Influenza

[PDF-1.24 MB]

English

Details Related Documents You May Also Like

Details:

Personal Author:

Chang, Lee-Jah
Corporate Authors:

Sanofi Pasteur.
Conference Authors:

United States. Advisory Committee on Immunization Practices. Meeting (2019 October 23-24, 2019 : Atlanta, GA)
Subjects:

[+]

Influenza Vaccines
Series:

ACIP meeting Influenza
Document Type:

Presentation
Name as Subject:

ACIP meeting: 2019 Oct ; ACIP meeting: 2019 Oct

ACIP meeting: 2019 Oct ; ACIP meeting: 2019 Oct Less -
Genre:

Conference Publications
Volume:

201903
Issue:

010403
Collection(s):

Advisory Committee on Immunization Practices (ACIP)
Main Document Checksum:

[+]

urn:sha256:26312f44dfc97b7b048a4364d0edb9c4f81af8191b005ed24e16beadc0b69c11
Download URL:

https://stacks.cdc.gov/view/cdc/83327/cdc_83327_DS1.pdf
File Type:

No Additional Files

More +

QIV-HD clinical development and phase 3 safety and immunogenicity study results

Details:

Supporting Files

Related Documents

You May Also Like